Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÖzbek, Emin
dc.contributor.authorOtunçtemur, Alper
dc.contributor.authorŞahin, Süleyman
dc.contributor.authorÖzcan, Levent
dc.contributor.authorDursun, Murat
dc.contributor.authorPolat, Emrecan
dc.contributor.authorTülübaş, Feti
dc.contributor.authorÇekmen, Mustafa
dc.date.accessioned2022-05-11T14:42:06Z
dc.date.available2022-05-11T14:42:06Z
dc.date.issued2016
dc.identifier.issn1677-5538
dc.identifier.issn1677-6119
dc.identifier.urihttps://doi.org/10.1590/S1677-5538.IBJU.2015.0453
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9216
dc.description.abstractObjective: SUI, involuntary loss of urine, occurs when intra abdominal pressure exceeds urethral pressure in women. Recent animal study has shown that there are therapeutic effects of Insulin-like growth factors (IGF-1) on stress urinary incontinence in rats with simulated childbirth trauma. IGF-1 is an important mediator of cell growth, differentiation and transformation in various tissues and stimulates fibroblast proliferation and enhances collagen synthesis. The purpose of the current study was to determine the association between IGF-1 levels and SUI. Materials and Methods: All patients were evaluated for SUI and divided into two groups: 116 women with SUI and 76 women without SUI. Diagnosis of SUI was based on the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Levels of IGF-1 were measured in serum by enzyme-linked immunosorbent assay. The relationship between IGF-1 levels and SUI in patients was evaluated statisticaly. Results: The mean age of patients wiyh SUI was 49.9 +/- 8.6 and 48.7 +/- 7.8 in control group. Plasma IGF-1 levels were significantly lower in SUI than in control group (106.5 +/- 26.4 and 133.3 +/- 37.1ng/mL, respectively, P < 0.001). Body mass indexes were higher in women with SUI than women without SUI. Conclusion: In this study lower serum IGF-1 levels were found to be associated with SUI. Serum IGF-1 level appears to be a specific predictor of SUI, and it may be used in early prediction of SUI in female population.en_US
dc.language.isoengen_US
dc.publisherBrazilian Soc Urolen_US
dc.identifier.doi10.1590/S1677-5538.IBJU.2015.0453
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectUrinary Incontinence, Stressen_US
dc.subjectEnzyme-Linked Immunosorbent Assayen_US
dc.subjectInsulin-Like Growth Factor Ien_US
dc.subjectPeriurethral Connective-Tissueen_US
dc.subjectPelvic Flooren_US
dc.subjectBiochemical-Compositionen_US
dc.subjectWomenen_US
dc.subjectCollagenen_US
dc.subjectProlapseen_US
dc.subjectExpressionen_US
dc.subjectContinenten_US
dc.subjectIgf-1en_US
dc.titleLow serum Insulin Like Growth Factor-1 in patients with Stress Urinary Incontinenceen_US
dc.typearticleen_US
dc.relation.ispartofInternational Braz J Urolen_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalıen_US
dc.authorid0000-0001-8617-3639
dc.authorid0000-0001-5254-2563
dc.authorid0000-0003-0679-2873
dc.authorid0000-0001-9115-7203
dc.authorid0000-0002-0553-3012
dc.identifier.volume42en_US
dc.identifier.issue4en_US
dc.identifier.startpage787en_US
dc.identifier.endpage792en_US
dc.institutionauthorTülübaş, Feti
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid24492292800
dc.authorscopusid25026476400
dc.authorscopusid56023692600
dc.authorscopusid36937882500
dc.authorscopusid35768988000
dc.authorscopusid33768003100
dc.authorscopusid8514414100
dc.authorwosidÖzcan, Levent/AAV-8512-2021
dc.authorwosidPolat, Emre Can/ABI-4703-2020
dc.authorwosiddursun, murat/C-6318-2019
dc.authorwosidErkoc, Mustafa/AAE-2641-2019
dc.identifier.wosWOS:000391024000022en_US
dc.identifier.scopus2-s2.0-84991080331en_US
dc.identifier.pmid27564291en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster